Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1992-10-16
pubmed:abstractText
Cultured bovine aortic endothelial cells (BAEC) released endothelin-1 (ET-1) in the culture medium in a time-dependent fashion. Coincubation of fMLP-activated human polymorphonuclear leukocytes (PMN) with BAEC caused a fast (maximal activity was reached within 15 minutes) and cell number-dependent disappearance of ET-1 from the medium. This effect was direct to ET-1, because it was also present when PMN were incubated with the synthetic peptide in the absence of BAEC. PMN-dependent disappearance of ET-1 was associated with loss of constrictor activity on isolated rabbit aorta. PMN-released products were responsible for ET-1 degrading activity, because supernatants of activated PMN were equally effective as the intact cells. Resting PMN, in the same time frame, were uneffective. Eglin C, a potent blocker of PMN-derived elastase and cathepsin G, reversed the ET-1 inhibitory activity of fMLP-stimulated PMN and of their supernatant. Direct addition of elastase and cathepsin G to synthetic ET-1 destroyed its immunoreactivity and this effect was blocked by eglin C. High-performance liquid chromatography (HPLC) analysis supported the hypothesis that ET-1 degradation by PMN was due to enzymatic proteolysis. These data provide evidence that activated PMN are able to degrade ET-1 through the release of proteases. Because physiologic concentrations of PMN can destroy high amounts (up to 100 nmol/L) of ET-1 within a few minutes, we propose that this mechanism of ET-1 inactivation has biologic relevance.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0006-4971
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
78
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2715-20
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:1824263-Animals, pubmed-meshheading:1824263-Aorta, pubmed-meshheading:1824263-Cathepsin G, pubmed-meshheading:1824263-Cathepsins, pubmed-meshheading:1824263-Cattle, pubmed-meshheading:1824263-Cells, Cultured, pubmed-meshheading:1824263-Culture Media, pubmed-meshheading:1824263-Endopeptidases, pubmed-meshheading:1824263-Endothelins, pubmed-meshheading:1824263-Endothelium, Vascular, pubmed-meshheading:1824263-Humans, pubmed-meshheading:1824263-Kinetics, pubmed-meshheading:1824263-Muscle, Smooth, Vascular, pubmed-meshheading:1824263-N-Formylmethionine Leucyl-Phenylalanine, pubmed-meshheading:1824263-Neutrophils, pubmed-meshheading:1824263-Pancreatic Elastase, pubmed-meshheading:1824263-Protease Inhibitors, pubmed-meshheading:1824263-Rabbits, pubmed-meshheading:1824263-Serine Endopeptidases, pubmed-meshheading:1824263-Vasoconstriction
pubmed:year
1991
pubmed:articleTitle
Inactivation of endothelin by polymorphonuclear leukocyte-derived lytic enzymes.
pubmed:affiliation
University of Chieti G. D'Annunzio, School of Medicine, Italy.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't